Skip to main content
. 2016 May 4;6:7. doi: 10.1186/s13569-016-0047-1

Table 3.

Sarcoma advisory group guidelines for osteosarcoma

Category 1st line 2nd line 3rd line and other
Resectable <30 years Doxorubicin, cisplatin methotrexate ± mifamurtide [101] Ifosfamide and etoposide [102] Gemcitabine and docetaxel [103] or oral etoposide
Other Doxorubicin, cisplatin ± methotrexate [101] Ifosfamide, etoposide ± methotrexate Gemcitabine and docetaxel [103] or oral etoposide

Taken from: London and South East Sarcoma Network (LSESN) Guidelines [98]